{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:00:06Z","timestamp":1795089606444,"version":"4.10.2"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2019R1A2C2008541"],"award-info":[{"award-number":["NRF-2019R1A2C2008541"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Interstitial lung disease associated with primary Sj\u00f6gren\u2019s syndrome (SJS-ILD) has a variable clinical course. We aimed to investigate the role of blood biomarkers in predicting prognosis for SJS-ILD. Clinical data of 46 SJS-ILD patients were retrospectively reviewed. Plasma biomarker levels, including Krebs von den Lungen-6 (KL-6), CC chemokine ligand 18 (CCL18), chitinase-3-like-1 (YKL-40), interleukin-4 receptor alpha (IL-4Ra), and matrix metalloproteinase-7 (MMP-7) were measured using the multiplex Luminex assays (R&amp;D Systems, Minneapolis, USA). The median follow-up period was 69.0\u00a0months. The mean age of the patients was 59.4\u00a0years; 17.4% were men. The KL-6 level was significantly higher in non-survivors (n\u2009=\u200912; 119.6 vs. 59.5\u00a0pg\/mL, <jats:italic>P<\/jats:italic>\u2009=\u20090.037) than survivors (n\u2009=\u200934), while the levels of the other biomarkers did not differ. Receiver operating characteristic analysis indicated that KL-6 shows the best performance for predicting survival (area under the curve\u2009=\u20090.705, <jats:italic>P<\/jats:italic>\u2009=\u20090.037; best cut-off value\u2009=\u200953.5\u00a0pg\/mL). Multivariable Cox analysis that was adjusted by age and diffusing capacity for carbon monoxide suggested a high KL-6 level (&gt;\u200953.5\u00a0pg\/mL) as an independent prognostic factor for survival (hazard ratio\u2009=\u20095.939, 95% confidence interval 1.312\u201326.881, <jats:italic>P<\/jats:italic>\u2009=\u20090.021). Our results suggest that blood KL-6 might be a useful in predicting the prognosis for patients with SJS-ILD.<\/jats:p>","DOI":"10.1038\/s41598-022-09283-w","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T01:03:36Z","timestamp":1648602216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Blood KL-6 predicts prognosis in primary Sj\u00f6gren\u2019s syndrome-associated interstitial lung disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Yun Jae","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jooae","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Jin","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Woo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,29]]},"reference":[{"key":"9283_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/ard.58.7.423","volume":"58","author":"M Pertovaara","year":"1999","unstructured":"Pertovaara, M. et al. Clinical follow up study of 87 patients with sicca symptoms (dryness of eyes or mouth, or both). Ann. Rheum. Dis. 58, 423\u2013427. https:\/\/doi.org\/10.1136\/ard.58.7.423 (1999).","journal-title":"Ann. Rheum. Dis."},{"key":"9283_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/ard.2004.025676","volume":"64","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals, M., Tzioufas, A. G. & Font, J. Primary Sjogren\u2019s syndrome: New clinical and therapeutic concepts. Ann. Rheum. Dis. 64, 347\u2013354. https:\/\/doi.org\/10.1136\/ard.2004.025676 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"9283_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/s2213-2600(17)30433-2","volume":"6","author":"DA Lynch","year":"2018","unstructured":"Lynch, D. A. et al. Diagnostic criteria for idiopathic pulmonary fibrosis: A Fleischner Society White Paper. Lancet Respir. Med. 6, 138\u2013153. https:\/\/doi.org\/10.1016\/s2213-2600(17)30433-2 (2018).","journal-title":"Lancet Respir. Med."},{"key":"9283_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ccm.2010.05.007","volume":"31","author":"M Kokosi","year":"2010","unstructured":"Kokosi, M., Riemer, E. C. & Highland, K. B. Pulmonary involvement in Sjogren syndrome. Clin. Chest Med. 31, 489\u2013500. https:\/\/doi.org\/10.1016\/j.ccm.2010.05.007 (2010).","journal-title":"Clin. Chest Med."},{"key":"9283_CR5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s11882-013-0357-9","volume":"13","author":"G Stojan","year":"2013","unstructured":"Stojan, G., Baer, A. N. & Danoff, S. K. Pulmonary manifestations of Sj\u00f6gren\u2019s syndrome. Curr. Allergy Asthma Rep. 13, 354\u2013360. https:\/\/doi.org\/10.1007\/s11882-013-0357-9 (2013).","journal-title":"Curr. Allergy Asthma Rep."},{"key":"9283_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4046\/trd.2019.0009","volume":"82","author":"SM Koo","year":"2019","unstructured":"Koo, S. M., Kim, S. Y., Choi, S. M. & Lee, H. K. Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 5. Connective tissue disease associated interstitial lung disease. Tuberc. Respir. Dis. (Seoul). 82, 285\u2013297. https:\/\/doi.org\/10.4046\/trd.2019.0009 (2019).","journal-title":"Tuberc. Respir. Dis. (Seoul)."},{"key":"9283_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/rheumatology\/kes311","volume":"52","author":"O Palm","year":"2013","unstructured":"Palm, O. et al. Clinical pulmonary involvement in primary Sjogren\u2019s syndrome: Prevalence, quality of life and mortality\u2014A retrospective study based on registry data. Rheumatology (Oxford) 52, 173\u2013179. https:\/\/doi.org\/10.1093\/rheumatology\/kes311 (2013).","journal-title":"Rheumatology (Oxford)"},{"key":"9283_CR8","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1093\/rheumatology\/kev200","volume":"54","author":"M Ramos-Casals","year":"2015","unstructured":"Ramos-Casals, M. et al. Characterization of systemic disease in primary Sj\u00f6gren\u2019s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology (Oxford) 54, 2230\u20132238. https:\/\/doi.org\/10.1093\/rheumatology\/kev200 (2015).","journal-title":"Rheumatology (Oxford)"},{"key":"9283_CR9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","volume":"87","author":"M Ramos-Casals","year":"2008","unstructured":"Ramos-Casals, M. et al. Primary Sj\u00f6gren syndrome in Spain: Clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 87, 210\u2013219. https:\/\/doi.org\/10.1097\/MD.0b013e318181e6af (2008).","journal-title":"Medicine (Baltimore)"},{"key":"9283_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073774","volume":"8","author":"Y Enomoto","year":"2013","unstructured":"Enomoto, Y. et al. Prognostic factors in interstitial lung disease associated with primary Sj\u00f6gren\u2019s syndrome: A retrospective analysis of 33 pathologically-proven cases. PLoS ONE 8, e73774. https:\/\/doi.org\/10.1371\/journal.pone.0073774 (2013).","journal-title":"PLoS ONE"},{"key":"9283_CR11","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1164\/rccm.200403-417OC","volume":"171","author":"I Ito","year":"2005","unstructured":"Ito, I. et al. Pulmonary manifestations of primary Sjogren\u2019s syndrome: A clinical, radiologic, and pathologic study. Am. J. Respir. Crit. Care Med. 171, 632\u2013638. https:\/\/doi.org\/10.1164\/rccm.200403-417OC (2005).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"9283_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2019.105811","volume":"159","author":"Y Kamiya","year":"2019","unstructured":"Kamiya, Y. et al. Prognostic factors for primary Sj\u00f6gren\u2019s syndrome-associated interstitial lung diseases. Respir. Med. 159, 105811. https:\/\/doi.org\/10.1016\/j.rmed.2019.105811 (2019).","journal-title":"Respir. Med."},{"key":"9283_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1465-9921-6-78","volume":"6","author":"A Tzouvelekis","year":"2005","unstructured":"Tzouvelekis, A., Kouliatsis, G., Anevlavis, S. & Bouros, D. Serum biomarkers in interstitial lung diseases. Respir. Res. 6, 78. https:\/\/doi.org\/10.1186\/1465-9921-6-78 (2005).","journal-title":"Respir. Res."},{"key":"9283_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s002960000064","volume":"19","author":"S Fukaya","year":"2000","unstructured":"Fukaya, S. et al. KL-6 as a novel marker for activities of interstitial pneumonia in connective tissue diseases. Rheumatol. Int. 19, 223\u2013225. https:\/\/doi.org\/10.1007\/s002960000064 (2000).","journal-title":"Rheumatol. Int."},{"key":"9283_CR15","first-page":"1112","volume":"31","author":"K Yanaba","year":"2004","unstructured":"Yanaba, K., Hasegawa, M., Takehara, K. & Sato, S. Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis. J. Rheumatol. 31, 1112\u20131120 (2004).","journal-title":"J. Rheumatol."},{"key":"9283_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/crj.12341","volume":"11","author":"Y Hu","year":"2017","unstructured":"Hu, Y. et al. Serum Krebs von den Lungen-6 level as a diagnostic biomarker for interstitial lung disease in Chinese patients. Clin. Respir. J. 11, 337\u2013345. https:\/\/doi.org\/10.1111\/crj.12341 (2017).","journal-title":"Clin. Respir. J."},{"key":"9283_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13075-019-1835-9","volume":"21","author":"JS Lee","year":"2019","unstructured":"Lee, J. S. et al. Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease. Arthritis Res. Ther. 21, 58. https:\/\/doi.org\/10.1186\/s13075-019-1835-9 (2019).","journal-title":"Arthritis Res. Ther."},{"key":"9283_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pulmoe.2018.05.008","volume":"25","author":"H Qin","year":"2019","unstructured":"Qin, H. et al. Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease. Pulmonology 25, 143\u2013148. https:\/\/doi.org\/10.1016\/j.pulmoe.2018.05.008 (2019).","journal-title":"Pulmonology"},{"key":"9283_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229997","volume":"15","author":"HC Kim","year":"2020","unstructured":"Kim, H. C., Choi, K. H., Jacob, J. & Song, J. W. Prognostic role of blood KL-6 in rheumatoid arthritis-associated interstitial lung disease. PLoS ONE 15, e0229997. https:\/\/doi.org\/10.1371\/journal.pone.0229997 (2020).","journal-title":"PLoS ONE"},{"key":"9283_CR20","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1183\/09031936.00004711","volume":"38","author":"KP Tiev","year":"2011","unstructured":"Tiev, K. P. et al. Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis. Eur. Respir. J. 38, 1355\u20131360. https:\/\/doi.org\/10.1183\/09031936.00004711 (2011).","journal-title":"Eur. Respir. J."},{"key":"9283_CR21","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3899\/jrheum.170373","volume":"44","author":"H Hozumi","year":"2017","unstructured":"Hozumi, H. et al. Clinical utility of YKL-40 in polymyositis\/dermatomyositis-associated interstitial lung disease. J. Rheumatol. 44, 1394\u20131401. https:\/\/doi.org\/10.3899\/jrheum.170373 (2017).","journal-title":"J. Rheumatol."},{"key":"9283_CR22","first-page":"919","volume":"138","author":"H Shen","year":"2013","unstructured":"Shen, H., Xia, L. & Lu, J. Interleukin-4 in rheumatoid arthritis patients with interstitial lung disease: A pilot study. Indian J. Med. Res. 138, 919\u2013921 (2013).","journal-title":"Indian J. Med. Res."},{"key":"9283_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1189\/jlb.1204712","volume":"78","author":"E Schutyser","year":"2005","unstructured":"Schutyser, E., Richmond, A. & Van Damme, J. Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes. J. Leukoc. Biol. 78, 14\u201326. https:\/\/doi.org\/10.1189\/jlb.1204712 (2005).","journal-title":"J. Leukoc. Biol."},{"key":"9283_CR24","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/art.22559","volume":"56","author":"A Prasse","year":"2007","unstructured":"Prasse, A. et al. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. Arthritis Rheum. 56, 1685\u20131693. https:\/\/doi.org\/10.1002\/art.22559 (2007).","journal-title":"Arthritis Rheum."},{"key":"9283_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-physiol-012110-142250","volume":"73","author":"CG Lee","year":"2011","unstructured":"Lee, C. G. et al. Role of chitin and chitinase\/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu. Rev. Physiol. 73, 479\u2013501. https:\/\/doi.org\/10.1146\/annurev-physiol-012110-142250 (2011).","journal-title":"Annu. Rev. Physiol."},{"key":"9283_CR26","doi-asserted-by":"publisher","first-page":"e25631","DOI":"10.1097\/md.0000000000025631","volume":"100","author":"X Tong","year":"2021","unstructured":"Tong, X. et al. Can YKL-40 be used as a biomarker for interstitial lung disease? A systematic review and meta-analysis. Medicine (Baltimore) 100, e25631. https:\/\/doi.org\/10.1097\/md.0000000000025631 (2021).","journal-title":"Medicine (Baltimore)"},{"key":"9283_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1164\/rccm.201101-0058OC","volume":"185","author":"TJ Richards","year":"2012","unstructured":"Richards, T. J. et al. Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 185, 67\u201376. https:\/\/doi.org\/10.1164\/rccm.201101-0058OC (2012).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"9283_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12931-015-0280-9","volume":"16","author":"A Sokai","year":"2015","unstructured":"Sokai, A. et al. Matrix metalloproteinase-10: A novel biomarker for idiopathic pulmonary fibrosis. Respir. Res. 16, 120. https:\/\/doi.org\/10.1186\/s12931-015-0280-9 (2015).","journal-title":"Respir. Res."},{"key":"9283_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez065","author":"Y Nakatsuka","year":"2019","unstructured":"Nakatsuka, Y. et al. Serum matrix metalloproteinase levels in polymyositis\/dermatomyositis patients with interstitial lung disease. Rheumatology (Oxford) https:\/\/doi.org\/10.1093\/rheumatology\/kez065 (2019).","journal-title":"Rheumatology (Oxford)"},{"key":"9283_CR30","first-page":"323","volume":"48","author":"C Am\u0103linei","year":"2007","unstructured":"Am\u0103linei, C., C\u0103runtu, I. D. & B\u0103lan, R. A. Biology of metalloproteinases. Roman. J. Morphol. Embryol Revue roumaine de morphologie et embryologie. 48, 323\u2013334 (2007).","journal-title":"Roman. J. Morphol. Embryol Revue roumaine de morphologie et embryologie."},{"key":"9283_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12931-016-0343-6","volume":"17","author":"A Pardo","year":"2016","unstructured":"Pardo, A., Cabrera, S., Maldonado, M. & Selman, M. Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis. Respir. Res. 17, 23. https:\/\/doi.org\/10.1186\/s12931-016-0343-6 (2016).","journal-title":"Respir. Res."},{"key":"9283_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski, C. H. et al. 2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sj\u00f6gren\u2019s Syndrome: A consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. Hoboken NJ. 69, 35\u201345. https:\/\/doi.org\/10.1002\/art.39859 (2017).","journal-title":"Arthritis Rheumatol. Hoboken NJ."},{"key":"9283_CR33","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/ard.2009.110619","volume":"69","author":"R Seror","year":"2010","unstructured":"Seror, R. et al. EULAR Sjogren\u2019s syndrome disease activity index: Development of a consensus systemic disease activity index for primary Sjogren\u2019s syndrome. Ann. Rheum. Dis. 69, 1103\u20131109. https:\/\/doi.org\/10.1136\/ard.2009.110619 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"9283_CR34","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","volume":"200","author":"BL Graham","year":"2019","unstructured":"Graham, B. L. et al. Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society Technical Statement. Am. J. Respir. Crit. Care Med. 200, e70\u2013e88. https:\/\/doi.org\/10.1164\/rccm.201908-1590ST (2019).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"9283_CR35","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00016-2016","author":"BL Graham","year":"2017","unstructured":"Graham, B. L. et al. 2017 ERS\/ATS standards for single-breath carbon monoxide uptake in the lung. Eur. Respir. J. https:\/\/doi.org\/10.1183\/13993003.00016-2016 (2017).","journal-title":"Eur. Respir. J."},{"key":"9283_CR36","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1183\/09031936.05.00035005","volume":"26","author":"J Wanger","year":"2005","unstructured":"Wanger, J. et al. Standardisation of the measurement of lung volumes. Eur. Respir. J. 26, 511\u2013522. https:\/\/doi.org\/10.1183\/09031936.05.00035005 (2005).","journal-title":"Eur. Respir. J."},{"key":"9283_CR37","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1183\/09031936.00150314","volume":"44","author":"AE Holland","year":"2014","unstructured":"Holland, A. E. et al. An official European Respiratory Society\/American Thoracic Society technical standard: Field walking tests in chronic respiratory disease. Eur. Respir. J. 44, 1428\u20131446. https:\/\/doi.org\/10.1183\/09031936.00150314 (2014).","journal-title":"Eur. Respir. J."},{"key":"9283_CR38","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","volume":"185","author":"KC Meyer","year":"2012","unstructured":"Meyer, K. C. et al. An official American Thoracic Society clinical practice guideline: The clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am. J. Respir. Crit. Care Med. 185, 1004\u20131014. https:\/\/doi.org\/10.1164\/rccm.201202-0320ST (2012).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"9283_CR39","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1164\/rccm.200703-463PP","volume":"176","author":"HR Collard","year":"2007","unstructured":"Collard, H. R. et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 176, 636\u2013643. https:\/\/doi.org\/10.1164\/rccm.200703-463PP (2007).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"9283_CR40","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1148\/radiol.13130187","volume":"270","author":"D Assayag","year":"2014","unstructured":"Assayag, D. et al. Rheumatoid arthritis-associated interstitial lung disease: Radiologic identification of usual interstitial pneumonia pattern. Radiology 270, 583\u2013588. https:\/\/doi.org\/10.1148\/radiol.13130187 (2014).","journal-title":"Radiology"},{"key":"9283_CR41","doi-asserted-by":"publisher","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","volume":"156","author":"B Ley","year":"2012","unstructured":"Ley, B. et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann. Intern. Med. 156, 684\u2013691. https:\/\/doi.org\/10.7326\/0003-4819-156-10-201205150-00004 (2012).","journal-title":"Ann. Intern. Med."},{"key":"9283_CR42","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1378\/chest.13-1474","volume":"145","author":"CJ Ryerson","year":"2014","unstructured":"Ryerson, C. J. et al. Predicting survival across chronic interstitial lung disease: The ILD-GAP model. Chest 145, 723\u2013728. https:\/\/doi.org\/10.1378\/chest.13-1474 (2014).","journal-title":"Chest"},{"key":"9283_CR43","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.rmed.2014.04.009","volume":"108","author":"S Ohshimo","year":"2014","unstructured":"Ohshimo, S. et al. Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis. Respir. Med. 108, 1031\u20131039. https:\/\/doi.org\/10.1016\/j.rmed.2014.04.009 (2014).","journal-title":"Respir. Med."},{"key":"9283_CR44","doi-asserted-by":"publisher","first-page":"e26777","DOI":"10.1097\/md.0000000000026777","volume":"100","author":"H Gao","year":"2021","unstructured":"Gao, H. et al. Characteristics and mortality in primary Sj\u00f6gren syndrome-related interstitial lung disease. Medicine (Baltimore) 100, e26777. https:\/\/doi.org\/10.1097\/md.0000000000026777 (2021).","journal-title":"Medicine (Baltimore)"},{"key":"9283_CR45","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/rheumatology\/ker267","volume":"50","author":"JF Boitiaux","year":"2011","unstructured":"Boitiaux, J. F. et al. Idiopathic interstitial lung disease with anti-SSA antibody. Rheumatology (Oxford) 50, 2245\u20132250. https:\/\/doi.org\/10.1093\/rheumatology\/ker267 (2011).","journal-title":"Rheumatology (Oxford)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09283-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09283-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09283-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:02:36Z","timestamp":1669338156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09283-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,29]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9283"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-09283-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,29]]},"assertion":[{"value":"9 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5343"}}